180 results
Keyword ipilimumab Remove keyword
-
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 April 2018
European Medicines Agency, London, UK, from 23/04/2018 to 26/04/2018, Last updated: 08/06/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 February 2018
European Medicines Agency, London, UK, from 19/02/2018 to 22/02/2018, Last updated: 06/04/2018 -
List item
Paediatric Committee (PDCO): 23-26 January 2018
European Medicines Agency, London, UK, from 23/01/2018 to 26/01/2018, Last updated: 10/04/2018 -
List item
Paediatric Committee (PDCO): 12-14 August 2015
European Medicines Agency, London, UK, from 12/08/2015 to 14/08/2015, Last updated: 19/02/2013 -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 September 2017
European Medicines Agency, London, UK, from 11/09/2017 to 14/09/2017, Last updated: 06/01/2014 -
List item
Paediatric Committee (PDCO): 21-24 February 2017
European Medicines Agency, London, UK, from 21/02/2017 to 24/02/2017, Last updated: 03/07/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 25-28 January 2016
European Medicines Agency, London, UK, from 25/01/2016 to 28/01/2016, Last updated: 25/01/2016 -
List item
Paediatric Committee (PDCO): 13-16 December 2016
European Medicines Agency, London, UK, from 13/12/2016 to 16/12/2016, Last updated: 30/06/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 15-18 May 2017
European Medicines Agency, London, UK, from 15/05/2017 to 18/05/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 17-20 September 2018
European Medicines Agency, London, UK, from 17/09/2018 to 20/09/2018, Last updated: 31/10/2018